About Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency is a rare disease catalogued by Orphanet (ORPHA:90794). Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries worldwide.
Clinical Trial Eligibility Tips
What to know before applying to Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency trials.
Search ClinicalTrials.gov for "Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency" or Orphanet code ORPHA:90794 to find disease-specific recruiting studies.
Ask your specialist to refer you to an Orphanet-accredited Centre of Expertise for this condition.
Natural history studies and patient registries often open enrolment before drug trials — contact the Orphanet patient community first.
Patient Resources
Find recruiting Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Updated daily.